Linqi Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Nature communications

Emerging microbes & infections

Science translational medicine

PLoS pathogens

Tsinghua University School of Medicine

Beijing Normal University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tsinghua University School of Medicine Jan 01 2008

China

Direcotr and Professor :: Comprehensive AIDS Research Center

Aaron Diamond Aids Research Center Mar 15 1993 - Dec 31 2007

United States

Postdoc/Staff Investigator/Assistant/Associate Professor :: The Rockefeller University

University of Edinburgh Mar 15 1992 - Mar 14 1993

United Kingdom

Postdoctoral fellow :: Genetics

Education History

Beijing Normal University Sep 01 1981 - Jul 31 1985

China

BSC :: Biology

Publications

Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Juanjuan Wang, Haoran An, Ming Ding, Yanhong Liu, Shaomeng Wang, Qian Jin, Qi Wu, Haodi Dong, Qile Guo, Xianbin Tian, Jiankai Liu, Jingfei Zhang, Tao Zhu, Junqiang Li, Zhujun Shao, David E Briles, Jan-Willem van Groenigen, Haifa Zheng, Linqi Zhang, Jing-Ren Zhang
Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteria. Science translational medicine 15 (727) (2023)
Bin Ju, Qi Zhang, Ziyi Wang, Zhen Qin Aw, Peng Chen, Bing Zhou, Ruoke Wang, Xiangyang Ge, Qining Lv, Lin Cheng, Rui Zhang, Yi Hao Wong, Huixin Chen, Haiyan Wang, Sisi Shan, Xuejiao Liao, Xuanling Shi, Lei Liu, Justin Jang Hann Chu, Xinquan Wang, Zheng Zhang, Linqi Zhang
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants. Nature immunology (2023)
Juanjuan Wang, Haoran An, Ming Ding, Yanhong Liu, Shaomeng Wang, Qian Jin, Qi Wu, Haodi Dong, Qile Guo, Xianbin Tian, Jiankai Liu, Jingfei Zhang, Tao Zhu, Junqiang Li, Zhujun Shao, David E Briles, Jan-Willem van Groenigen, Haifa Zheng, Linqi Zhang, Jing-Ren Zhang
Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteria. Science translational medicine 15 (727) (2023)
Juanjuan Wang, Haoran An, Ming Ding, Yanhong Liu, Shaomeng Wang, Qian Jin, Qi Wu, Haodi Dong, Qile Guo, Xianbin Tian, Jiankai Liu, Jingfei Zhang, Tao Zhu, Junqiang Li, Zhujun Shao, David E Briles, Jan-Willem van Groenigen, Haifa Zheng, Linqi Zhang, Jing-Ren Zhang
Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteria. Science translational medicine 15 (727) (2023)
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi Zhang, Zheng Zhang, Justin Jang Hann Chu, Xinquan Wang, Linqi Zhang
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nature communications 13 (1) (2022)
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi Zhang, Zheng Zhang, Justin Jang Hann Chu, Xinquan Wang, Linqi Zhang
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nature communications 13 (1) (2022)
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi Zhang, Zheng Zhang, Justin Jang Hann Chu, Xinquan Wang, Linqi Zhang
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nature communications 13 (1) (2022)
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi Zhang, Zheng Zhang, Justin Jang Hann Chu, Xinquan Wang, Linqi Zhang
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nature communications 13 (1) (2022)
Hai Qi, Bo Liu, Xinquan Wang, Linqi Zhang
The humoral response and antibodies against SARS-CoV-2 infection. Nature immunology 23 (7) (2022)
Xiaoshuang Liu, Xiao Xu, Guanqiao Li, Xian Xu, Yuyao Sun, Fei Wang, Xuanling Shi, Xiang Li, Guotong Xie, Linqi Zhang
Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States. BMC public health 21 (1) (2021)
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Yanan Zuo, Lan-Yi Zhong, Shu-Mei Yan, Xiao Zhang, Ziqing Yang, Yong-Jian Peng, Xuanling Shi, Su-Mei Cao, Xinquan Wang, Mu-Sheng Zeng, Linqi Zhang
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature communications 12 (1) (2021)
Jiaojiao Liu, Kun Xu, Man Xing, Yue Zhuo, Jingao Guo, Meng Du, Qi Wang, Yaling An, Jinhe Li, Ping Gao, Yihan Wang, Furong He, Yingying Guo, Mingxi Li, Yuchao Zhang, Linqi Zhang, George Fu Gao, Lianpan Dai, Dongming Zhou
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell discovery 7 (1) (2021)
Qi Zhang, Bin Ju, Jiwan Ge, Jasper Fuk-Woo Chan, Lin Cheng, Ruoke Wang, Wei Jin Huang, Mengqi Fang, Peng Chen, Bing Zhou, Shuo Song, Sisi Shan, Baohua Yan, Senyan Zhang, Xiangyang Ge, Jiazhen Yu, Juanjuan Zhao, Haiyan Wang, Li Liu, Qining Lv, Lili Fu, Xuanling Shi, Kwok-Yung Yuen, Lei Liu, You-Chun Wang, Zhiwei Chen, Linqi Zhang, Xinquan Wang, Zheng Zhang
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nature communications 12 (1) (2021)
Xiaohui Ju, Yunkai Zhu, Yuyan Wang, Jingrui Li, Jiaxing Zhang, Mingli Gong, Wenlin Ren, Sai Li, Jin Zhong, Linqi Zhang, Qiangfeng Cliff Zhang, Rong Zhang, Qiang Ding
A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS pathogens 17 (3) (2021)
Renhong Yan, Ruoke Wang, Bin Ju, Jinfang Yu, Yuanyuan Zhang, Nan Liu, Jia Wang, Qi Zhang, Peng Chen, Bing Zhou, Yaning Li, Yaping Shen, Shuyuan Zhang, Long Tian, Yingying Guo, Lu Xia, Xinyue Zhong, Lin Cheng, Xiangyang Ge, Juanjuan Zhao, Hong-Wei Wang, Xinquan Wang, Zheng Zhang, Linqi Zhang, Qiang Zhou
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell research 31 (5) (2021)
Jiwan Ge, Ruoke Wang, Bin Ju, Qi Zhang, Jing Sun, Peng Chen, Senyan Zhang, Yuling Tian, Sisi Shan, Lin Cheng, Bing Zhou, Shuo Song, Juanjuan Zhao, Haiyan Wang, Xuanling Shi, Qiang Ding, Lei Liu, Jin-Cun Zhao, Zheng Zhang, Xinquan Wang, Linqi Zhang
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Nature communications 12 (1) (2021)
Bin Ju, Qi Zhang, Jiwan Ge, Ruoke Wang, Jing Sun, Xiangyang Ge, Jiazhen Yu, Sisi Shan, Bing Zhou, Shuo Song, Xian Tang, Jinfang Yu, Jun Lan, Jing Yuan, Haiyan Wang, Juanjuan Zhao, Shuye Zhang, You-Chun Wang, Xuanling Shi, Lei Liu, Jin-Cun Zhao, Xinquan Wang, Zheng Zhang, Linqi Zhang
Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584 (7819) (2020)
Qian Wang, Bingting Ma, Qingtai Liang, Angqi Zhu, Hua Wang, Lili Fu, Xiaoxu Han, Xuanling Shi, Ye Xiang, Hong Shang, Linqi Zhang
Stabilized diverse HIV-1 envelope trimers for vaccine design. Emerging microbes & infections 9 (1) (2020)
Wenxu Jia, Rudragouda Channappanavar, Chao Zhang, Mingxi Li, Haixia Zhou, Shuyuan Zhang, Panpan Zhou, Jiuyang Xu, Sisi Shan, Xuanling Shi, Xinquan Wang, Jincun Zhao, Dongming Zhou, Stanley Perlman, Linqi Zhang
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerging microbes & infections 8 (1) (2019)
Jiuyang Xu, Wenxu Jia, Pengfei Wang, Senyan Zhang, Xuanling Shi, Xinquan Wang, Linqi Zhang
Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerging microbes & infections 8 (1) (2019)
Panpan Zhou, Han Wang, Mengqi Fang, Yangyang Li, Hua Wang, Shasha Shi, Zihao Li, Jiapeng Wu, Xiaoxu Han, Xuanling Shi, Hong Shang, Tongqing Zhou, Linqi Zhang
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies. PLoS pathogens 15 (6) (2019)

Linqi Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Linqi Zhang